Industry Recognition & Accreditation
-
WindRose Health Investors Recapitalizes Terrapin Pharmacy
Market Watch | January 18, 2022 -
The Helper Bees Secures $12.8 Million Series B Funding To Build Out Aging-In-Place Platform
Market Watch | January 18, 2022 -
Kaiser Permanente Joins Digital Health Company Graphite Health
Market Watch | January 18, 2022 -
FDA Grants Breakthrough Device Designation To JelikaLite For Cognilum Wearable Device To Reduce Autism Symptoms In Children Ages 2 To 6
Market Watch | January 11, 2022 -
Department Of Justice Awards More Than $100 Million To Support Youth
Market Watch | January 4, 2022 -
Ophelia Raises $50 Million In Series B Funding, Led by Tiger Global, To Expand Its Novel Approach To Opioid Addiction Treatment
Market Watch | December 28, 2021 -
Robin Healthcare Raises $50 Million For Its Ambient Medical Scribe Device To Document Physician Office Visits
Market Watch | December 28, 2021 -
BestSelf Behavioral Health Receiving $5 Million In Federal Funding To Enhance Mental Health Care
Market Watch | December 14, 2021 -
DOJ Selects Advocates For Human Potential For Renewed $1 Million Grant To Provide Training & Technical Assistance For Jails & Prisons Participating In The Residential Substance Abuse Treatment Program
Market Watch | December 14, 2021 -
Michael J. Fox Foundation Awards $2 Million To Fund A Clinical Trial Of Ketamine To Treat People With Parkinson’s Disease & Depression
Market Watch | December 10, 2021 -
Cala Health Raised $77 Million To Expand Consumer Access To Wearable Bioelectronic Treatment For Essential Tremor; May Expand Into Other Indications, Including Psychiatry
Market Watch | December 7, 2021 -
ieso, UK-Based Digital Mental Health Provider Organization, Raised $53 Million
Market Watch | December 7, 2021 -
Emotional Intelligence Ventures Raises $20 Million To Pursue Psilocybin Transdermal Delivery Research
Market Watch | December 7, 2021 -
atai Life Sciences Increases Ownership Position In COMPASS Pathways Based On Positive Clinical Trial Outcomes Of Psilocybin-Based Treatment For Resistant Major Depression
Market Watch | December 7, 2021 -
Bexson Biomedical Receives FDA Guidance On Developing Wearable Ketamine For Pain, Now Expanding To Treat Major Depression
Market Watch | November 29, 2021